INMB (INmune Bio, Inc.) Forward P/E Multiple
Diversification of oncology and Alzheimer's disease programs reduces patent risks for INmune Bio, Inc. (INMB). The company's forward P/E ratio visualizes this process, and the current value of the indicator is 0.00. Expert management is effectively structuring the clinical trial strategy. However, the lack of profitable products creates a negative cash flow, which is temporarily offset by external investments.
Analytical breakdowns for INmune Bio, Inc.
- current price and projected stock value:
- business market valuation indicators:
- book capitalization information:
- debt and liquidity details:
- company profitability and valuation multiples indicators:
INMB - Company Profit|Expected Profit INmune Bio, Inc.|INMB - Price to Earnings Ratio|Projected Price to Earnings INmune Bio Corp|INMB - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization INmune Bio Inc|INMB - Operating profit before amortization|Net earnings per share (EPS TTM) INmune Bio|INMB - Net earnings per one share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months inmunebio.com|INMB - Earnings per share increase in current year|Earnings growth forecast for next year INmune Bio, Inc.
Summary company analytics:INmune Bio
FDA regulatory hurdles and chronic liquidity shortages at INmune Bio, Inc. (INMB) make traditional earnings-based valuations difficult. The forward P/E ratio relates current market capitalization to expected earnings, determining the capital payback period based on given forecasts, which allows the trend of the company's forward P/E ratio to differentiate temporary undervaluation from systemic business decline.
Competitors of INmune Bio, Inc. (INMB)
Projected Price to Earnings ARGX (argenx)|BNTX (BioNTech Inc.) - Future Price to Earnings Multiple|Forward P/E Multiple ABVX (abivax.com)|Market Cap to Projected Earnings ADMA Corp (ADMA)|PTGX - Future Price to Earnings|immunovant.com (IMVT) - Projected Price to Earnings|Kiniksa (KNSA) - Future Price to Earnings|Projected Price to Earnings Grifols SA|Projected Price to Earnings ADPT|Forward P/E Multiple Celldex Corp|Future Price to Earnings Aurinia Pharmaceuticals (AUPH)|biocryst.com - Price to Future Earnings Ratio|Forward P/E Multiple VERA (Vera Therapeutics)|Dianthus Therapeutics Inc (DNTH) - Projected Price to Earnings Ratio|Pharvaris Corp - Forward P/E Multiple|Market Cap to Projected Earnings AbCellera Biologics ABCL|Tourmaline Bio, Inc. (TRML) - Future Price to Earnings|Price to Future Earnings Ratio PGEN|Future Price to Earnings Pharming Group|Projected Price to Earnings Nektar Therapeutics Inc (NKTR)|Projected Price to Earnings UPB (Upstream Bio Corp)|Forward P/E Multiple Zenas Corp (ZBIO)|Future Price to Earnings Immunome, Inc. IMNM|GOSS: Price to Future Earnings Ratio|KalVista Pharmaceuticals, Inc. - Forward P/E Multiple|Projected Price to Earnings Ratio Septerna, Inc.|PVLA (Pieris Pharmaceuticals Inc) - Projected Price to Earnings|Savara Pharma - Future Price to Earnings Multiple|RIGL (Rigel Pharmaceuticals) - Forward P/E Multiple|Future Price to Earnings ANAB|Forward P/E Multiple ATXS|Market Cap to Projected Earnings enGene Holdings Inc|Future Price to Earnings RAPT Therapeutics, Inc. RAPT|Aerovate Therapeutics, Inc. (JBIO) - Projected Price to Earnings Ratio|ACRS: Projected Price to Earnings|Future Price to Earnings Multiple KYTX (kyvernatx.com)|TLSA: Forward P/E Multiple|CABA - Market Cap to Projected Earnings|Future Price to Earnings Ventyx Bio|Price to Future Earnings Ratio THTX (Theratechnologies, Inc)|Forward P/E Multiple AVTX|Projected Price to Earnings eledon.com ELDN|Agenus Inc. - Projected Price to Earnings|Market Cap to Projected Earnings Climb Bio Inc. (CLYM)|Zura Bio Limited - Forward P/E Multiple|Market Cap to Projected Earnings aTyr Pharmaceuticals ATYR|adagene.com (ADAG) - Future Price to Earnings|Price to Future Earnings Ratio IMA|Future Price to Earnings Shattuck Labs Inc|Projected Price to Earnings Equillium Bio (EQ)|Forward P/E Multiple CNTB|Future Price to Earnings IMUX (immunic-therapeutics.com)|Future Price to Earnings Atara Bio ATRA|IFRX (InflaRx NV) - Price to Expected Earnings Ratio|X4 Pharmaceuticals, Inc. - Forward P/E Multiple|Future Price to Earnings Multiple ACET (Adicet Bio)|CELU: Forward P/E Multiple|Barinthus Biotherapeutics Corp (BRNS) - Forward P/E Multiple|Future Price to Earnings Kezar Life Sciences|SABS: Future Price to Earnings Multiple|Future Price to Earnings Akari Therapeutics Plc (AKTX)|Projected Price to Earnings enlivex.com ENLV|Forward P/E Multiple QTTB (Q32 Bio)|Forward P/E Multiple GeoVax Corp GOVX|EDSA: Projected Price to Earnings|Future Price to Earnings Multiple IBIO (ibioinc.com)|CARM: Forward P/E Multiple|XTLB - Market Cap to Projected Earnings|Future Price to Earnings Bolt Biotherapeutics Inc.|Projected Price to Earnings HCW Biologics Inc (HCWB)|Future Price to Earnings Aptevo Therapeutics (APVO)|Projected Price to Earnings AIM ImmunoTech, Inc. AIM|Aditxt, Inc. - Projected Price to Earnings|Forward P/E Multiple GRI Bio Inc GRI|XRTX - Future Price to Earnings|HIND (Vyome Therapeutics) - Price to Future Earnings Ratio|REVB: Forward P/E Multiple|Projected Price to Earnings Ratio indaptusrx.com (INDP)|SCNI (Scinai Immunotherapeutics Ltd.) - Forward P/E Multiple|CalciMedica Corp (CALI) - Market Cap to Projected Earnings|Future Price to Earnings Affimed (AFMD)|allakos.com - Price to Future Earnings Ratio|Future Price to Earnings HOOKIPA Pharma HOOK|IGMS - Projected Price to Earnings|ITOS: Projected Price to Earnings|OCEA - Forward P/E Multiple|TC BioPharm (Holdings) PLC (TCBP) - Future Price to Earnings|Price to Future Earnings Ratio THRD
